Funding

ARTAN Bio

United States · Biotech · Healthtech

Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions

Visit artan.bioFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$200KVitaDAO — Role not disclosed

Investors

VitaDAOSeed

Coverage

Jun 4, 2026ARTAN Bio · Seed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesartan.bio ↗